首页> 外文期刊>American Journal of Nephrology >Mesenteric ischemia in patients with end-stage renal disease: A nationwide longitudinal study
【24h】

Mesenteric ischemia in patients with end-stage renal disease: A nationwide longitudinal study

机译:终末期肾脏疾病患者的肠系膜缺血:一项全国性纵向研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background and Aims: Mesenteric ischemia is an uncommon disorder associated with an extremely high mortality rate. Only limited studies have evaluated this lethal disease among patients with end-stage renal disease (ESRD). The objective of this study was to evaluate the risks of mesenteric ischemia among ESRD patients and compare the incidence between two dialysis modalities. Methods: Records of all ESRD patients older than 20 years of age from 1998 to 2007 and a control group consisting of 1 million records were retrieved from the Taiwan National Health Insurance Research Database. Hospitalizations for mesenteric ischemic events were retrieved using ICD-9-CM diagnosis codes and ICD-9-CM operation codes from inpatient claims. Results: Among 55,807 incident ESRD patients who received hemodialysis or peritoneal dialysis, there were 458 mesenteric ischemic events, corresponding to an incidence rate of 2.7 per 1,000 patient-years. Multivariate Cox regression analysis indicated that the independent risk factors were old age (HR 1.42 per 10 years), diabetes (HR 2.85), peripheral vascular disease (HR 2.66), atrial fibrillation (HR 2.15), heart failure (HR 1.65), chronic pulmonary disease (HR 1.41), neoplasm (HR 1.54), peptic ulcer disease (HR 1.86), and peritoneal dialysis (HR 1.51, all p < 0.05). There was no effect of dialysis modality on the mesenteric ischemia mortality rate. Conclusion: The risk of mesenteric ischemia for ESRD patients was 44.1 (95% confidence interval 13.4-106.2, p < 0.001) times higher than that of the general population. Compared to hemodialysis, peritoneal dialysis was associated with a higher risk of mesenteric ischemia.
机译:背景与目的:肠系膜缺血是一种罕见的疾病,死亡率极高。只有有限的研究评估了终末期肾病(ESRD)患者的这种致命疾病。这项研究的目的是评估ESRD患者肠系膜缺血的风险,并比较两种透析方式之间的发生率。方法:从台湾国家健康保险研究数据库中检索1998年至2007年所有20岁以上ESRD患者的记录,以及一个包含100万记录的对照组。使用ICD-9-CM诊断代码和ICD-9-CM操作代码从住院患者索赔中检索了肠系膜缺血事件的住院治疗。结果:在55807例接受血液透析或腹膜透析的ESRD患者中,发生了458次肠系膜缺血事件,对应每千患者年2.7的发生率。多元Cox回归分析显示,独立的危险因素为老年(每10年HR 1.42),糖尿病(HR 2.85),周围血管疾病(HR 2.66),房颤(HR 2.15),心力衰竭(HR 1.65),慢性肺部疾病(HR 1.41),肿瘤(HR 1.54),消化性溃疡疾病(HR 1.86)和腹膜透析(HR 1.51,所有p <0.05)。透析方式对肠系膜缺血死亡率没有影响。结论:ESRD患者的肠系膜缺血风险比普通人群高44.1倍(95%置信区间13.4-106.2,p <0.001)。与血液透析相比,腹膜透析与肠系膜缺血的风险更高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号